ClinicalTrials.gg
RecruitingNCT06814509Updated Jun 26, 2026

Delivering HOPE (Helping Women Optimize Prenatal Equity)

An interventional study of Enhanced Standard of Care (ESoC) and Delivering HOPE in Gestational Weight Gain, Diet, Healthy and Gestational Hypertension, sponsored by University of Arkansas. Recruiting at 8 sites in United States. Open to female participants aged 16 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-26.

Sponsored by University of Arkansas · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,440
Allocation
Randomized
Ages
16 Years to 44 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 61 studies in Gestational Weight Gain with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Gestational Weight Gain · United States.

Planned enrollment
2nd of 55
1,440 · median 70
Started
2025
with 4 others
No phase
53 of 61
11 open now
Primary completion
2029-06
later than 14 of 14 live
Registered
55th of 61
by date

Among the 61 studies in Gestational Weight Gain with a site in United States, this one is the 2nd largest by planned enrollment of the 55 interventional ones that give a count, is one of 5 that started in 2025, is one of 53 with no phase, reaches primary completion later than 14 of the 14 other live ones, and was the 55th registered.

Gestational Weight Gain

135 studies on the registry are indexed under Gestational Weight Gain; 24 are open to participants now.

Browse Gestational Weight Gain studies →

Open to participants now

12 of the 61 studies in Gestational Weight Gain with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 21 Gestational Weight Gain studies recruiting now, 7 (33%) set no upper age limit and 14 (67%) stop at 75 or younger; 4 take children under 18; 12 take healthy volunteers.

This study: 16 Years to 44 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 61 studies in Gestational Weight Gain with a site in United States, or all of them as a file.
02

Study summary

The overarching research question is: "Does the provision of healthy food (Delivering HOPE) during pregnancy reduce the proportion of women who experience excessive gestational weight gain compared with enhanced standard of care (ESoC)?" To answer this question, the investigators will conduct a large multi-site randomized controlled trial with 1,440 women. Women will be randomized to either the Delivering HOPE arm or the ESoC arm, with approximately 720 participants per arm. Participants randomized to the ESoC arm will receive the standard clinical protocol for nutritional and gestational weight gain counseling recommended for all pregnant women, WIC and SNAP enrollment assistance, referrals to safety net food organizations.Those randomized to the Delivering HOPE arm will be provided the same nutritional and gestational weight gain counseling, WIC and SNAP assistance, and food referrals, as well as a total of $1000/$2000/$3000 (depending on household size) during pregnancy to be used specifically for the purchase of healthy foods recommended in the nutritional counseling. Data for the primary outcome (pre-pregnancy weight and weight at delivery) will be collected from birth records.

03

Conditions studied

  • Gestational Weight Gain
  • Diet, Healthy
  • Gestational Hypertension
  • Gestational Diabetes
  • Pregnancy Complications
04

Who can participate

Ages eligible
16 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Aged 16-44 years
  • ≤18 weeks pregnant
  • Speak English, Spanish, or Marshallese
  • Valid email address
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,440 participants (estimated)

Study arms

  • Active comparator
    Enhanced Standard of Care (ESoC)

    The ESoC arm includes implementing a standard clinical protocol for nutritional and gestational weight gain counseling recommended for all pregnant women; implementing a standard protocol for helping participants sign up for WIC and SNAP; and implementing a standard protocol for providing referrals to safety net food organizations.

    Behavioral: Enhanced Standard of Care (ESoC)

  • Experimental
    Delivering HOPE

    The Delivering HOPE arm includes providing the same nutritional and gestational weight gain counseling, WIC and SNAP assistance, and referral assistance as ESoC. In addition, participants in the Delivering HOPE arm will be provided with funds during their pregnancy to be used specifically for the purchase of healthy foods. The amount will vary based on household size as follows: $1,000 (one to two household members), $2,000 (three to four household members), or $3,000 (five plus household members).

    Behavioral: Delivering HOPE

Interventions

  • BehavioralEnhanced Standard of Care (ESoC)

    Standard recommended nutrition and gestational weight gain counseling; WIC and SNAP enrollment assistance; emergency food referrals

  • BehavioralDelivering HOPE

    ESoC plus healthy food provision

06

What researchers measure

Primary outcomes

  1. Excessive gestational weight gain (EGWG)

    Pre-pregnancy weight and weight immediately prior to birth will be used to calculate total weight gain, adjusting for pre-pregnancy body mass index and weeks of gestation. Individuals whose total weight gain exceeds established guidelines will be determined to have EGWG. We will examine the difference in the proportion of women who experience EGWG.

    Time frame: Baseline to Post-partum (approx. 40 weeks)

07

Study locations

7 of 8 sites recruiting
  • 1st Choice Healthcare
    Corning, Arkansas 72422, United States
    Recruiting
  • River Valley Primary Care Services
    Lavaca, Arkansas 72941, United States
    Recruiting
  • Olly Neal Community Health Center
    Marianna, Arkansas 72360, United States
    Recruiting
  • Boston Mountain Rural Health Center
    Marshall, Arkansas 72650, United States
    Recruiting
  • Mainline Health Systems
    Monticello, Arkansas 71655, United States
    Recruiting
  • Jefferson Comprehensive Care System
    Pine Bluff, Arkansas 71601, United States
    Withdrawn

    Not enrolling at this site.

  • Community Clinic
    Springdale, Arkansas 72764, United States
    Recruiting
  • East Arkansas Family Health Center
    West Memphis, Arkansas 72301, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Jun 2029, 48 months after the start.

Of 84 non-industry interventional studies with no phase under Gestational Weight Gain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 38. This study's planned 48 months is above that.

Counting every sponsor, half of 84 studies reached it within 24 months; a quarter within 13 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Feb 7, 2025
StartActual
Jun 24, 2025
Primary completionEst.
Jun 30, 2029
CompletionEst.
Dec 31, 2029
Last update
Jun 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06814509
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Sponsor
First posted
Feb 7, 2025
Start date
Jun 24, 2025
Primary completion
Jun 30, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Jun 26, 2026

Study contacts

Brett Rowland
Contact
mbrowland@uams.edu
479-713-8000
Sarah Pollock
Contact
SPollack@uams.edu
479-713-8000
Pearl McElfish, PhD
principal investigator · University of Arkansas
Lanita White, PharmD
principal investigator · Community Health Centers of Arkansas

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion